Glucuronic acid is a novel source of pentosidine, associated with schizophrenia

• Published in: Redox biology 2023-11, Vol.67, p.102876-102876, Article 102876
• Main Authors: Toriumi, Kazuya, Iino, Kyoka, Ozawa, Azuna, Miyashita, Mitsuhiro, Yamasaki, Syudo, Suzuki, Kazuhiro, Sugawa, Hikari, Tabata, Koichi, Yamaguchi, Satoshi, Usami, Satoshi, Itokawa, Masanari, Nishida, Atsushi, Nagai, Ryoji, Kamiguchi, Hidenori, Arai, Makoto
• Format: Article
• Language: English
• Subjects: Advanced glycation end-products; Aldo-keto reductase; Glucuronic acid; Pentosidine; Research Paper; Schizophrenia
• ISSN: 2213-2317; 2213-2317
• DOI: 10.1016/j.redox.2023.102876

Pentosidine (PEN) is an advanced glycation end-product (AGEs), where a fluorescent cross-link is formed between lysine and arginine residues in proteins. Accumulation of PEN is associated with aging and various diseases. We previously reported that a subpopulation of patients with schizophrenia showed PEN accumulation in the blood, having severe clinical features. PEN is thought to be produced from glucose, fructose, pentoses, or ascorbate. However, patients with schizophrenia with high PEN levels present no elevation of these precursors of PEN in their blood. Therefore, the molecular mechanisms underlying PEN accumulation and the molecular pathogenesis of schizophrenia associated with PEN accumulation remain unclear. Here, we identified glucuronic acid (GlcA) as a novel precursor of PEN from the plasma of subjects with high PEN levels. We demonstrated that PEN can be generated from GlcA, both in vitro and in vivo. Furthermore, we found that GlcA was associated with the diagnosis of schizophrenia. Among patients with high PEN, the proportion of those who also have high GlcA is 25.6%. We also showed that Aldo-keto reductase (AKR) activity to degrade GlcA was decreased in patients with schizophrenia, and its activity was negatively correlated with GlcA levels in the plasma. This is the first report to show that PEN is generated from GlcA. In the future, this finding will contribute to understanding the molecular pathogenesis of not only schizophrenia but also other diseases with PEN accumulation. [Display omitted] •GlcA was accumulated in the plasma of subjects with high PEN levels.•PEN can be generated from GlcA, both in vitro and in vivo.•GlcA was associated with diagnosis of schizophrenia.•AKR activity to degrade GlcA was decreased in patients with schizophrenia.